White Paper

Accelerate Your Process Development With High-Throughput, Single-Use, Fully Automated Bioreactors

Source: Sartorius Stedim Biotech

By Mwai Ngibuini

POS-ambr_250_1472x1170_PRINT

Biopharmaceutical R&D teams everywhere face the same dilemma in the development of biologics and vaccines: they must increase productivity to meet strict budgets and deadlines, while maintaining or improving data accuracy.

In order to meet market demands, biopharmaceutical companies are increasingly turning to bioreactor technology that allows for high-throughput process development and optimization for both microbial fermentations and cell culture processes.